Publications

Found 6 results
Filters: Author is Donegan, Rebecca K  [Clear All Filters]
2015
R. K. Donegan and Lieberman, R. L., “Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.”, J Med Chem, 2015.
S. E. Hill, Donegan, R. K., Nguyen, E., Desai, T. M., and Lieberman, R. L., “Molecular Details of Olfactomedin Domains Provide Pathway to Structure-Function Studies.”, PLoS One, vol. 10, no. 6, p. e0130888, 2015.
R. K. Donegan, Hill, S. E., Freeman, D. M., Nguyen, E., Orwig, S. D., Turnage, K. C., and Lieberman, R. L., “Structural basis for misfolding in myocilin-associated glaucoma.”, Hum Mol Genet, vol. 24, no. 8, pp. 2111-24, 2015.
2014
S. E. Hill, Donegan, R. K., and Lieberman, R. L., “The glaucoma-associated olfactomedin domain of myocilin forms polymorphic fibrils that are constrained by partial unfolding and peptide sequence.”, J Mol Biol, vol. 426, no. 4, pp. 921-35, 2014.
2012
R. K. Donegan, Hill, S. E., Turnage, K. C., Orwig, S. D., and Lieberman, R. L., “The glaucoma-associated olfactomedin domain of myocilin is a novel calcium binding protein.”, J Biol Chem, vol. 287, no. 52, pp. 43370-7, 2012.
R. K. Donegan and Lieberman, R. L., “New direction for glaucoma therapeutics: focus on the olfactomedin domain of myocilin.”, Future Med Chem, vol. 4, no. 17, pp. 2131-4, 2012.